← Evidence map

ArticleOncotarget2016

miR-424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancer.

Xia Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 27769049